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Abstract
Background: Serous epithelial ovarian cancer (SEOC) is a highly metastatic disease and its progression has been
implicated with microRNAs. This study aimed to identify the differentially expressed microRNAs in Malaysian
patients with SEOC and examine the microRNAs functional roles in SEOC cells.
Methods: Twenty-two SEOC and twenty-two normal samples were subjected to miRNA expression profiling using
the locked nucleic acid (LNA) quantitative real-time PCR (qPCR). The localization of miR-200c was determined via
LNA in situ hybridization (ISH). Functional analysis of miR-200c and miR-31 on cell proliferation, migration and
invasion and clonogenic cell survival were assessed in vitro. The putative target genes of the two miRNAs were
predicted by miRWalk program and expression of the target genes in SEOC cell lines was validated.
Results: The miRNA expression profiling revealed thirty-eight significantly dysregulated miRNAs in SEOC compared to
normal ovarian tissues. Of these, eighteen were up-regulated whilst twenty miRNAs were down-regulated. We
observed chromogenic miR-200c-ISH signal predominantly in the cytoplasmic compartment of both epithelial and
inflammatory cancer cells. Re-expression of miR-200c significantly increased the cell proliferation and colony formation
but reduced the migration and invasion of SEOC cells. In addition, miR-200c expression was inversely proportionate
with the expression of deleted in liver cancer-1 (DLC-1) gene. Over-expression of miR-31 in SEOC cells resulted in
decreased cell proliferation, clonogenic potential, cell migration and invasion. Meanwhile, miR-31 gain-of-function led
to the down-regulation of AF4/FMR2 family member 1 (AFF1) gene.
Conclusions: These data suggested that miR-200c and miR-31 may play roles in the SEOC metastasis biology and
could be considered as promising targets for therapeutic purposes.
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Background
Ovarian cancer ranks as the third most common gynaeco-
logical malignancy worldwide with approximately 225,000
new cases been reported in 2011 [1]. This malignancy rep-
resents the fourth most frequently diagnosed in Malaysia
and becoming a major cause of deaths in Malaysian
women [2]. Epithelial ovarian cancer accounts for 90 % of
all ovarian cancer and is a highly heterogeneous tumor,
encompassing several histotypes with unique molecular
profiles and clinical features [3]. It includes serous, endo-
metrioid, mucinous and clear cell, with serous being the
most common among all [4]. Malpica and colleagues de-
scribed a novel two-tier grading system that classified
SEOC into low-grade and high-grade [5] in which the lat-
ter has a higher tendency to metastasize [6].
Recently, microRNAs (miRNAs) have come into atten-
tion to better understand the molecular biology of SEOC.
MiRNAs belong to a class of endogenous small non-
coding RNAs family that negatively regulates mRNA at
the post-transcriptional level by partially binding to the 3’
* Correspondence: norfilza@ppukm.ukm.edu.my
1UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia,
Jalan Yaa'cob Latiff, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia
3Department of Physiology, Faculty of Medicine, Universiti Kebangsaan
Malaysia Medical Center, Jalan Yaacob Latiff, Bandar Tun Razak, 56000 Cheras,
Kuala Lumpur, Malaysia
Full list of author information is available at the end of the article
© 2015 Ibrahim et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ibrahim et al. Journal of Ovarian Research  (2015) 8:56 
DOI 10.1186/s13048-015-0186-7
untranslated region of the target mRNA [7]. It is known
that a single miRNA family could potentially target up to
500 genes and in silico analyses has shown that the 3' un-
translated region of a single gene can be targeted by sev-
eral different miRNAs [8]. To date, there are 2588 mature
human miRNAs which have been deposited into the miR-
Base Release 21 registry [9]. As master regulators of gene
expression, miRNAs can act as oncomiRs or tumor sup-
pressor miRNAs depending on their gene targets, and alter-
ations of miRNAs expression promote cancer development
and progression [10].
MiR-200c is one of the miR-200 family members and
is a marker for epithelial-mesenchymal transition (EMT)
in female reproductive cancers [11]. This miRNA family
is known for its role as the “guardian of the epithelial
phenotype” by suppressing the EMT-inducing transcrip-
tion factor, zinc finger E-box binding homeobox 1 and 2
(ZEB1 and ZEB2) and in turn upregulates the expression
of E-cadherin [12]. It has been reported that the loss of
miR-200c increases the cell motility and invasiveness in
breast, endometrial and ovarian cancer cell lines [11].
However, previous studies have shown that the re-
expression of miR-200c reduced cell migration but did
not affect E-cadherin expression in some cells, which
suggested that miR-200c may target other genes associ-
ated with cancer metastasis [11, 13].
Although functional studies of miRNAs in ovarian
cancer are steadily progressing, the knowledge on cer-
tain miRNAs for instance miR-31 is still lacking. Several
studies have reported miR-31 to be upregulated in colo-
rectal [14] and endometrial cancers [15] but downregu-
lated in breast [16], glioma [17] and prostate cancers
[18], suggesting its complexity role in cancer as it can
act either as oncogenic or tumor suppressing miRNAs,
depending on the origin of cancer. Since miR-31 known
for its complex expression and described as a master
regulator of metastasis [19], we aimed to study the roles
of miR-31 in regulating SEOC.
DLC-1 (Deleted in liver cancer-1) was initially isolated
from primary hepatocellular carcinoma [20]. The gene is
located on chromosome 8p21-22 and encodes a Rho
GTPase-activating protein [20]. DLC-1 is known for its
tumor and metastasis suppressive role in cancer by pri-
marily regulating the actin cytoskeleton organization, for-
mation of actin fibres and focal adhesions [21]. The loss of
DLC-1 was not only limited to liver cancer as it has also
proven to be frequently loss in multiple cancers such as
breast [22], colon [23] and ovarian cancer [24]. DLC-1
expression suppresses cell migration and invasion in colon
cancer cell lines and its loss is associated with high meta-
static potential [23]. However, the role of DLC-1 in SEOC
is still obscure.
Numbers of dysregulated miRNAs have been identified
using different platform approaches including microarray
[25–28] and sequencing [29, 30], which shows the deregu-
lation of miRNAs could potentially serve as the diagnostic
or prognostic markers specific for serous subtype of ovar-
ian cancer. Thus, it is of great need to improve the insights
of miRNA expression data that can provide promising bio-
markers for SEOC or targets for therapeutic strategy. This
study aimed to characterize the miRNA expression aberra-
tions in SEOC of Malaysian patients by using qPCR on a
panel of 85 cancer-related miRNAs followed by miRNA
expression validation. We then performed LNA-ISH to
visualize miRNA localization in the high-grade SEOC sam-
ples, subsequently expression profile in SEOC cell lines
and miRNA functional analyses.
Methods
Clinical samples
Twenty-two SEOC with evidence of metastasis and 22
unmatched normal ovarian tissues were retrieved from
the Department of Pathology, Universiti Kebangsaan
Malaysia Medical Centre, Malaysia. All tissues were ar-
chived formalin-fixed, paraffin embedded (FFPE) sam-
ples from patients who were diagnosed from 2006 to
2013. The samples were histologically verified using
hematoxylin and eosin staining to contain more than
70 % cancer cells by the pathologist. We obtained the
unmatched normal ovarian tissues from patients who
underwent total abdominal hysterectomy with bilateral
salphingo-oophorectomy for benign gynecological disor-
ders and confirmed to be free from cancer cells. Patients
with secondary tumors or who underwent chemotherapy
were excluded from this study. The study was approved by
the UKM Medical Research Ethics Committee (Ref: UKM
1.5.3.5/244/UKM-GUP-2011-286). The clinical features
were presented in Table 1.
Cell lines and culture condition
Two human SEOC cell lines, CAOV3 and SKOV3 (meta-
static) cells were purchased from the American Type
Culture Collection (Manassas, USA). SKOV3 cells were
maintained in McCoy’s 5A medium (Invitrogen, CA, USA)
supplemented with 10 % fetal bovine serum (FBS) (Invitro-
gen). CAOV3 cells were maintained in Dulbecco's modi-
fied Eagle's medium in 4.5 g/L glucose (Invitrogen)
supplemented with 10 % FBS (Invitrogen). Normal human
ovarian surface epithelial (HOSE) cells were purchased
from ScienCell Research Laboratories (CA, USA) and
maintained in ovarian epithelial cell medium supplemented
with 1 × ovarian epithelial cell growth supplement (Scien-
Cell Research Laboratories). All cell lines were maintained
at 37 °C in a humidified incubator containing 5 % CO2.
Total RNA isolation and quality assessments
Total cellular RNA containing miRNAs were isolated from
the FFPE samples using the High Pure miRNA Isolation
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kit (Roche Applied Science, Mannheim, Germany). Four
10 μm FFPE sections from each sample were pooled into
a 1.5 ml tube and subjected to deparaffinization xylene at
50 °C for 5 min. The specimens were washed with abso-
lute ethanol twice followed by protease digestion using
proteinase K at 55 °C for 3 h. The RNA isolation proced-
ure was continued according to the manufacturer’s proto-
col. The RNA quantity and purity were determined using
the NanoDrop® ND-1000 spectrophotometer (Thermo
Scientific, MA, USA) and RNA with OD260/280 ratios of
1.8–2.1. The RNA integrity was assessed with RNA Pico
6000 chip (RNA integrity number ≥ 2) and small RNA
chip was used to confirm the miRNA presence in the sam-
ple using the Agilent 2100 Bioanalyzer System (Agilent
Technologies, CA, USA).
MiRNA expression profiling
To determine the differentially expressed miRNAs between
the SEOC and the normal ovarian tissues, a two-step qPCR
was performed using the Cancer Focus microRNA PCR
panel (V1.AF) containing 85 miRNAs that have been previ-
ously reported to be related with cancer (Exiqon, Vedbaek,
Denmark) (Additional file 1: Table S1). A total of 10 ng
RNA was reverse transcribed to cDNA using the Universal
cDNA synthesis kit (Exiqon). The reverse transcription
was performed according to the manufacturer’s protocol
using the Applied Biosystems Veriti™ Thermal Cycler
(Applied Biosystems, CA, USA). The qPCR was then per-
formed using the Applied Biosystems 7500 Fast Real-Time
PCR System (Applied Biosystems). The run template (SDS
files) was downloaded from the Exiqon’s website.
Validation using Pick-and-Mix panel
We selected the most significantly up-regulated miRNAs
in the FFPE samples following the analysis of the Cancer
Focus Panel data to further validate the results. The
two-step qPCR was performed using miRNA-specific
primers in the Pick-&-Mix panel (Exiqon) consisting of
eight miRNAs (miR-7, miR-21, miR-31, miR-182, miR-
141, miR-200a, miR-200b and miR-200c) on the same
set of patients and normalized to miR-27a. This assay
was carried out using the Applied Biosystems 7500 Fast
Real-Time PCR System (Applied Biosystems) according
to the Exiqon’s protocol.
MiRNA locked-nucleic acid (LNA) in situ hybridization
(ISH)
Hsa-miR-200c detection probe (3′ and 5’- end labelled
with digoxigenin and LNA-modified) and miRCURY
LNA™ microRNA ISH Optimization Kit 2 containing miR-
21 probe, U6 snRNA (both miR-21 and U6 snRNA as
positive controls), scrambled miRNA LNA probe (as nega-
tive control) as well as miRNA ISH buffer were purchased
from Exiqon (Vedbaek, Denmark). The ISH procedure was
adapted from Nuovo with slight modifications [31].
Briefly, four μm of serial FFPE sections were mounted on
the Superfrost® Plus slides (Fisher Scientific, Pennsylvania,
USA). Sections were deparaffinized in fresh xylene and
dehydrated in absolute ethanol for 5 min each and air
dried. Then, 15 μg/ml of Proteinase K (Exiqon) was applied
onto the tissue and placed in the hybridization chamber at
37 °C for 30 min. The slides were then dipped in 1× PBS
for 30 s to inactivate the Proteinase K and washed with ab-
solute ethanol. The digoxigenin (DIG)-labeled probes were
denatured at 90 °C for 4 min. 2 pmol/μl of the probes
diluted with 1× ISH buffer (Exiqon) was applied onto the
tissue sections. Slides were placed on a hot plate at 60 °C
for 5 min and into the hybridization chamber at 37 °C for
15 h. On the following day, the coverslips were carefully
detached and the slides were washed in 0.2 % saline
sodium citrate and 2 % bovine serum albumin solution
(Sigma, Missouri, USA) at 4 °C for 10 min. The chromo-
genic detection of the miRNA LNA-ISH probe was per-
formed with anti-DIG-alkaline phosphatase conjugate
(1:200 dilution of the conjugate in blocking reagent) and
incubated at 37 °C for 30 min. The miRNA expression
was detected by 4-nitro-blue-tetrazolium and 5-bromo-
4-chloro-3-indolynitrolphosphate substrate (Roche
Applied Science). The slides were counterstained with
nuclear fast red (Roche Applied Science). For image ac-
quisition, the Nikon Eclipse 80i microscope (Nikon,
Melville, USA) integrated with the Image-Pro Express
6.0 software (Media Cybernetics, Silver Spring, USA)
was utilized. The sample images were captured with
200× magnification.
Table 1 Summarized information of samples
Characteristics Cancer samples Control samples
N (%) N (%)
Age (year)
Median age 53 [21-73] 51 [42-62]
≤50 6 (27.3 %) 10 (45.45 %)
> 50 16 (72.7 %) 12 (54.55 %)
Race
Malay 18 (81.8 %) 10 (45.45 %)
Chinese 4 (18.2 %) 10 (45.45 %)
Others 0 2 (9.1 %)
Stage
II 4 (18.2 %)
III 14 (63.6 %)
IV 4 (18.2 %)
Grade
Low-grade (WD) 2 (9.1 %)
High-grade (MD or PD) 20 (90.9 %)
WD well differentiated; MD moderately differentiated; PD poorly differentiated
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In silico miRNA target prediction analysis
To determine the miRNA-putative gene targets, we used
the comprehensive miRNA target prediction algorithm,
miRWalk, from the publicly available website, www.um
m.uni-heidelberg.de/apps/zmf/mirwalk/(March 2011 re-
lease). The database integrates ten miRNA target predic-
tion algorithms (including miRWalk itself ). The
miRNA-mRNA interactions which are predicted by at
least five algorithms out of 10 algorithms were retained.
Data mining from the cancer microarray database,
Oncomine (https://www.oncomine.org/), was utilized to
identify the candidate down-regulated genes (fold-
change < −2, p < 0.05) that involve in ovarian carcino-
genesis. The potential target gene list was narrowed
down by selecting cancer-related genes and pathways
using the DAVID Bioinformatics Resources v6.7 tool
(https://david.ncifcrf.gov) which is linked with the
Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway annotation. The gene list generated from the
pathway enrichment analysis was used to overlap with
the putative miRNA targets from miRWalk.
Transient transfection of mature miRNAs
Cells (5 × 105) were seeded into each well of a 6-well plate
and cultured in antibiotic-free culture media without
serum until reached 70 % confluency. Mature miRNA
molecules were transiently transfected into SEOC cell
lines using Lipofectamine 2000 (Invitrogen) in Opti-
MEM® I reduced serum medium (Invitrogen) at 150 nM
concentration. For gain-of-function experiments, we used
miRIDIAN miRNA mimics hsa-miR-200c-3p and hsa-
miR-31-5p together with scrambled miRNA mimic nega-
tive control (GE Healthcare Dharmacon, Inc., Lafayette,
CO, USA). While for loss-of-function experiments, miR-
CURY LNA miRNA inhibitors miR-200c-3p and miR-31-
5p (Exiqon) with scrambled miRNA inhibitor control
(Exiqon) were used. 5’ terminal fluorescein-labeled scram-
bled miRNA inhibitor control was employed to assess the
transfection efficiency using the BD FACSAria II flow
cytometer (BD Biosciences, San Jose, USA).
Gene expression analysis of miRNA-transfected SEOC cells
Total RNA was isolated from the miRNA-transfected
cells using the QIAzol lysis reagent and miRNeasy Mini
Kit (Qiagen, CA, USA) according to the manufacturer’s
protocol. Two μg of RNA template was converted to
cDNA using the High Capacity RNA-to-cDNA kit (Ap-
plied Biosystems). QPCR analysis was carried out for
miR-200c and miR-31 target genes, DLC-1 and AFF1,
respectively using the TaqMan® gene expression assay.
The expression values of the genes of interest in each of
the transfected cells were normalized to the expression
value of the endogenous control, GAPDH. Relative fold
change of the targeted gene levels between the
transfection groups were determined by the 2-ΔΔCT
method [32]. All experiment reactions were performed
in triplicates.
Cell proliferation assay
The SEOC cells (1 × 104) were seeded and cultured over-
night in a 96-well plate. On the following day, the cells
were transiently transfected with 150 nM miRNA mimics,
inhibitors and respective NC. The proliferation rate was
determined by PrestoBlue™ Cell Viability reagent (Invitro-
gen) at 48 h post-transfection according to the manufac-
turer’s protocol. The fluorescence was measured using a
microplate reader SkanIt RE for Varioskan Flash 2.4
(Thermo Fisher Scientific, Massachusetts, USA) at excita-
tion/emission wavelengths of 560/590 nm. Experiment
was performed in six replicates.
Colony formation assay
After 24 h transfection with 150 nM miR-200c and miR-
31 mimics, inhibitors and respective NC, 500 cells were
plated in a 6-well plate with complete media and the plate
was swirled to ensure an even distribution of the cell. The
cells were grown in 37 °C incubator with 5 % CO2 for
10 days with media replacement every 3 days. At day 10,
the media was removed and cells were washed twice with
PBS. The colonies were fixed with 50 % cold methanol for
10 min, dried and stained with 0.5 % crystal violet solution
for 30 min. In order to remove the excess staining, the
plate was washed three times with tap water. Images of
the stained plates were captured, and the cell colonies
containing more than 50 cells were counted. Each treat-
ment was performed in triplicates.
Transwell cell invasion and migration assay
The QCM™ 24-well Fluorimetric Cell Invasion assay kit
(ECM554; Chemicon) and the Migration kit (ECM509;
Chemicon) were used to assess the migration and inva-
sion properties of the miRNA-transfected SEOC cells.
The assays were carried out according to the manufac-
turer’s protocol. Both kits used an insert polycarbonate
membrane with an 8 μm pore size. The insert in the in-
vasion kit was pre-coated with a thin layer of ECMatrix™
which occluded the membrane pores and blocked the
migration of non-invasive cells. After 48 h transfection,
cells were harvested and re-suspended in a serum-free
medium. The upper chamber was filled with 300 μL cell
suspension in triplicate in a 24-well plate, and 500 μl of
complete medium was added to the bottom well. Fol-
lowing 24 h incubation, the cells that had not migrated
were pipetted out from the upper surface of the inserts,
and the cells that had migrated to the lower filters were
detached using the cell detachment solution. Images of
three random fields (×40 magnification) were captured
from each well. The migrated and invaded cells were lysed
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and the relative invasion was determined by fluorescence
with 480/520 nm filter set. The miRNA-transfected cells




QPCR data obtained from FFPE samples were analyzed to
identify the common miRNAs that are present in SEOC.
The CT values obtained from the expression profiling were
imported into the Exiqon GenEx Version 5.4.2 software in
.txt format. Pre-processing was done prior to data analysis
including (1) inter-plate calibration, (2) selecting reference
genes using the NormFinder and (3) normalization against
the endogenous control miRNA, which is miR-27a. For
the quality control step, principal component analysis
(PCA) plot was generated. To determine the significant
differentially expressed miRNAs, robust statistical analysis
using the Kruskal-Wallis and LIMMA tests were carried
out separately using a p-value < 0.05 and log2 fold-change
between ≤ −1.0 and ≥ 1.0. The overlapping miRNAs found
using both tests were subjected for further analysis. Out-
liers were identified by the data points that fall beyond
UQ+ 1.5.IQD or LQ-1.5.IQD in the box plot (UQ: upper
quartile, IQD: inter-quartile distance, LQ: lower quartile).
UQ and LQ are the 75th and 25th percentiles respectively.
Outliers were then replaced with the group median. Heat-
map analysis and hierarchical clustering were generated
using the R programming software for miRNA expression
pattern visualization. To further confirm the direction of
miRNAs expression, the significant miRNAs were sub-
jected to experimental validation.
MiRNA functional analysis
For miRNA functional analysis, all statistical analyses were
performed using GraphPad Prism 6.0 statistical software.
Experimental data was presented as mean ± standard devi-
ation (S.D.). The differences between groups were ana-
lyzed using Student’s t-test with a p < 0.05 was regarded as
statistically significant. All experiments were conducted in
triplicates to ensure reproducibility of the results.
Results
Differentially expressed miRNAs in metastatic SEOC
versus normal ovary
LNA™-qPCR was performed in order to determine the
dysregulated miRNAs in SEOC and normal ovarian tis-
sues. We obtained a total of 22 FFPE tissues from the
patients who had been diagnozed with SEOC that did
not receive chemotherapy. All of the samples had meta-
static evidence within the peritoneal cavity. Eighteen of
the patients were Malays and four were Chinese. There
was no SEOC FFPE sample from Indian or other races
included in this study. According to the FIGO
classification, four samples were in Stage II, 14 were in
stage III and four were from the Stage IV. Based on
Malpica’s 2-tier grading, two of the patients were diag-
nosed with low-grade SEOC and 20 of them were high-
grade SEOC. The clinicopathological data of the 22
patients of SEOC with metastasis evidence and 22 nor-
mal controls used in this study are shown in Table 1.
Prior to data analysis, the endogenous miRNA candi-
date that would serve as normalization control was de-
termined using the NormFinder software. MiR-27a was
found to be the most stably expressed miRNA in all
samples by having the lowest S.D. value which indicates
the miRNA is a good endogenous control for data
normalization. Thus, miR-27a was used to normalize the
miRNAs expression in both SEOC and normal ovarian
tissues. Out of 85 miRNAs analysed in the qPCR cancer
panel, 38 miRNAs was significantly dysregulated with a
log2 fold-change of either ≤ −1.0 or ≥ 1.0 with p < 0.05, of
which 18 miRNAs were up- and 20 were down-regulated
in SEOC compared to the normal samples (Tables 2 and 3).
The PCA plot clearly segregated the samples into two dis-
tinct groups; SEOC and normal ovarian samples (Fig. 1a).
The volcano plot illustrated the relationship between the –
log10 p-value and the log2 fold change in SEOC versus nor-
mal ovary samples (Fig. 1b). A representative hierarchical
clustering based on Euclidean algorithm was generated
with the heatmap where two distinctive expression profiles
were observed (Fig. 1c). The complete list of the 85 miR-
NAs evaluated across all the samples in this study is sum-
marized in Additional file 2: Table S2.
The Pick-&-Mix qPCR validation of selected miRNAs
QPCR validation results of the eight selected miRNAs
(miR-7, miR-21, miR-31, miR-182, miR-141, miR-200a,
miR-200b and miR-200c) showed concordance with the
qPCR analysis. These findings confirmed the miRNA ex-
pression profiling results as shown in Fig. 2.
MiR-200c predominantly localized in the cancer epithelia
The up-regulation and localization of miR-200c in SEOC
were further validated via ISH assay upon the intact
SEOC FFPE tissue. MiR-200c probe gave an intense
bluish ISH signal was readily detectable in the cytoplasm
of the epithelial cancer cells without background stain-
ing. Whereas, a weak miR-200c signal in the adjacent
stromal compartment was observed (Fig. 3a). MiR-200c
also displayed a dense blue chromogenic nucleoli stain-
ing in the SEOC case (Additional file 3: Figure S1). The
miR-21 ISH signal which act as another positive control
was also observed in the cytoplasmic compartment of
the cancer cells. The ISH signal for the U6 snRNA was
exclusively expressed in the nuclei of all cell types. In
addition, there was no specific ISH signal detected when
applying scrambled sequence probe which further
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Table 2 MicroRNAs significantly up-regulated in metastatic SEOC compared to normal ovarian tissues
miRID Adjusted p-value (Kruskal-Wallis) Adjusted p-value (LIMMA) log2 fold change Chromosomal location Cytogenetic band
Up-regulated
hsa-miR-200c 1.91E-07 2.64E-21 8.921469061 12: 6963699-6963766 [+] 12p13.31
hsa-miR-141 1.91E-07 1.12E-23 8.787092856 12: 6964097-6964191 [+] 12p13.31
hsa-miR-200b 1.91E-07 1.86E-21 8.699603684 1: 1167104-1167198 [+] 1p36.33
hsa-miR-200a 1.91E-07 1.06E-23 8.562872035 1: 1167863-1167952 [+] 1p36.33
hsa-miR-182 1.91E-07 1.13E-15 5.411527936 7: 129770383-129770492 [-] 7q32.2
hsa-miR-31 6.93E-05 3.77E-06 4.094320534 9: 21512115-21512185 [-] 9p21.3
hsa-miR-7 5.82E-07 1.72E-11 3.971773447 9: 83969748-83969857 [-] 9q21.32
hsa-miR-203 2.23E-05 2.36E-07 2.966799585 14: 104117405-104117514 [+] 14q32.33
hsa-miR-10a 0.000681963 2.62E-05 2.701327257 17: 48579838-48579947 [-] 17q21.32
hsa-miR-21 1.91E-07 1.23E-13 2.431890348 17: 59841266-59841337 [+] 17q23.1
hsa-miR-18a 1.95E-07 1.33E-09 2.329697689 13: 91350751-91350821 [+] 13q31.3
hsa-miR-93 1.91E-06 8.84E-08 1.947479146 7: 100093768-100093847 [-] 7q22.1
hsa-miR-20b 0.049868623 0.008417024 1.489542936 X: 134169809-134169877 [-] Xq26.2
hsa-miR-146a 0.002542269 0.000122875 1.38901606 5: 160485352-160485450 [+] 5q33.3
hsa-miR-155 0.000725017 0.000447306 1.209141398 21: 25573980-25574044 [+] 21q21.3
hsa-miR-15a 9.13E-05 3.75E-05 1.192194165 13: 50049119-50049201 [-] 13q14.2
hsa-miR-106a 9.77E-05 7.99E-05 1.140778656 X: 134170198-134170278 [-] Xq26.2
hsa-miR-210 0.002542269 0.000443277 1.015069322 11: 568089-568198 [-] 11p15.5
Table 3 MicroRNAs significantly down-regulated in metastatic serous ovarian cancer compared to normal ovarian tissues
miRID Adjusted p-value (Kruskal-Wallis) Adjusted p-value (LIMMA) log2 fold change Chromosomal location Cytogenetic band
Down-regulated
hsa-let-7a 1.18E-05 8.84E-08 −1.029 9: 94175957-94176036 [+] 9q22.32
hsa-miR-29a 0.000115739 1.75E-05 −1.032 7: 130876747-130876810 [-] 7q32.3
hsa-miR-126 9.83E-06 1.70E-06 −1.107 9: 136670602-136670686 [+] 9q34.3
hsa-miR-29c 0.000265228 9.82E-05 −1.148 1: 207801852-207801939 [-] 1q32.2
hsa-miR-132 0.001852309 0.000402718 −1.162 17: 2049908-2050008 [-] 17p13.3
hsa-miR-101 5.45E-05 1.42E-05 −1.352 1: 65058434-65058508 [-] 1p31.3
hsa-miR-26a 2.74E-07 1.71E-09 −1.373 3: 37969404-37969480 [+] 3p22.2
hsa-let-7b 8.28E-07 2.42E-09 −1.509 22: 46113686-46113768 [+] 22q13.31
hsa-miR-143 2.06E-06 1.58E-09 −1.953 5: 149428918-149429023 [+] 5q32
hsa-miR-9 0.000532847 0.000152253 −1.955 1: 156420341-156420429 [-] 1q22
hsa-let-7c 2.21E-06 1.72E-08 −1.966 21: 16539828-16539911 [+] 21q21.1
hsa-miR-214 2.06E-06 2.30E-08 −2.233 1: 172138798-172138907 [-] 1q24.3
hsa-miR-100 2.63E-07 2.73E-10 −2.369 11: 122152229-122152308 [-] 11q24.1
hsa-miR-125b 2.87E-07 4.47E-11 −2.488 11: 122099757-122099844 [-] 11q24.1
hsa-miR-202 6.46E-05 4.59E-05 −2.533 10: 133247511-133247620 [-] 10q26.3
hsa-miR-99a 1.91E-07 4.00E-12 −2.821 21: 16539089-16539169 [+] 21q21.1
hsa-miR-195 1.91E-07 1.46E-13 −2.945 17: 7017615-7017701 [-] 17p13.1
hsa-miR-145 7.96E-07 6.22E-10 −3.137 5: 149430646-149430733 [+] 5q32
hsa-miR-1 2.06E-06 2.04E-10 −3.426 20: 62554306-62554376 [+] 20q13.33
hsa-miR-133a 4.12E-05 4.92E-07 −3.705 18: 21825698-21825785 [-] 20q13.33
miRID: miRNA identifier from miRBase Release 21
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confirmed the probes’ specificity in detecting their respect-
ive miRNAs. We also detected inflammatory cells showed
strong ISH signal for miR-200c (Fig. 3b).
In silico analyses reveal the putative gene targets and
pathways of miRNAs
Given that a miRNA has the potential to target a large
number of genes, we employed a publicly available data-
base, miRWalk that consists of ten different prediction al-
gorithms, thus avoiding the false positive miRNA target
predictions. After integrating the Oncomine data (Adib et
al. 2004) with the results from the miRWalk in silico ana-
lysis, we identified that DLC-1 which was predicted by
eight target prediction algorithms as the potential target
of miR-200C. We employed similar strategies for miR-31
and identified AFF1 as the putative target for this miRNA,
predicted by six prediction algorithms. The canonical
pathways that may be regulated by the miRNAs were also
evaluated. The predicted cancer-related pathways are
summarized in Additional file 3: Table S3 for miR-200c
Fig. 1 MicroRNA (miRNA) expression profiling of SEOC and normal ovarian tissues. a The principal component analysis (PCA) plot generated a
clear segregation between SEOC (green) and normal ovarian tissues (red). b The volcano plot representing significance of identified miRNAs
which are differentially expressed with p < 0.05. The up-regulated miRNAs are shown in red while down-regulated miRNAs are shown in blue.
c Hierarchical clustering of the 38 differentially expressed (DE) miRNAs. Samples are designated along the vertical axis and clustered by the colour
bar in between the dendrogram and heatmap. Red denotes normal ovary group while yellow denotes SEOC group. The colour key illustrates the
miRNAs relative expression across all samples. Red illustrates higher expression level than the mean and yellow illustrates lower expression level
than the mean
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and Additional file 3: Table S4 for miR-31. It is worth stat-
ing that p53, MAPK and Wnt signalling pathways were
some of the pathways shared by both miRNAs, suggesting
the possible roles of these miRNAs upon the mentioned
pathways in resulting SEOC metastasis.
Quantitative analysis of miR-200c and miR-31 in SEOC cell
lines
We examined the miR-200c and miR-31 expression in two
SEOC cell lines; CAOV3 (primary tumor SEOC cell) and
SKOV3 (isolated from ascites) and in non-tumorigenic cell
(HOSE) using qPCR. As presented in Fig. 4, CAOV3 cell
expressed a higher level of miR-200c than HOSE whereas
SKOV3 expressed lower level of miR-200c than HOSE.
Meanwhile, the expression level of miR-31 was down-
regulated in both CAOV3 and SKOV3 cells relative to the
HOSE cells (p < 0.001), which surprisingly found to be
contradictory to the expression level that we observed in
the cancer tissue samples (Additional file 3: Figure S2).
Despite the discrepancy of miR-31 expression found in
cancer tissues and cultured cell lines, we next determine
whether the modulations of these miR-200c and miR-31
would have any effect on the biological behaviours of these
two SEOC cell lines.
Re-expression of miR-200c inhibited the mRNA DLC-1
level, enhanced proliferation and clonogenic potential
but suppressed invasion and migration of SEOC cells
We over-expressed or inhibit miR-200c in the SEOC
cells and examined changes in putative target mRNA,
cell proliferation, colony formation ability, cell invasion and
migration. Transfection efficiency was determined by a
flow-cytometric analysis of transfected exogenous miRNA
labeled with fluorescein (Additional file 3: Figure S3). The
3’ UTR of DLC-1 contains two putative binding sites for
miR-200c (Fig. 5a). Since the DLC-1 level was down-
regulated in SEOC, we hypothesized that there would be
significant changes in the expression level of DLC-1 upon
transfecting the cells with either miR-200c mimic or inhibi-
tors. Total RNA was purified from both CAOV3 and
SKOV3 at 48 h post-transfection with miR-200c mimics
and inhibitors, and DLC-1 expression level was quantified
by using the qPCR. Consistent with our hypothesis, we
discovered that over-expression of miR-200c reduced the
DLC-1 expression whereas the inhibition of miR-200c
resulted in up-regulation of DLC-1 expression (Fig. 5b).
As depicted in Fig. 5c, induced expression (gain-of-func-
tion) of mature miR-200c led to significant increase in
SEOC cell proliferation compared to the negative control.
Meanwhile, the delivery of miR-200c inhibitor into the
SEOC cell lines significantly reduced the cell proliferation.
Similar observation was seen in the colony formation
assay whereby the over-expression of miR-200c promoted
the clonogenic potential (Fig. 5d) and inhibition of miR-
200c caused suppression in the clonogenic potential as
relative to the negative controls in both cancer cell lines
(Fig. 5e). Next, we observed that over-expression of miR-
200c reduced the invasion of SEOC cells through the
ECMatrix™, whereas the inhibition of miR-200c promoted
the invasiveness of the SEOC cells (Fig. 5f). Likewise, the
migration of cells through the filter membrane was signifi-
cantly repressed in response to miR-200c mimic treatment
(Fig. 5g), whilst inhibition of miR-200c exhibited the op-
posite effects (Fig. 5h).
Over-expression of miR-31 down-regulated AFF1, sup-
pressed cell proliferation, clonogenic potential, migration
and invasion properties of SEOC cells
There are three predicted binding sites for miR-31 at the 3’
UTR of AFF1 gene (Fig. 6a). We found that AFF1 mRNA
level was negatively regulated by miR-31 (Fig. 6b). As
shown in Fig. 6c, the cell proliferation property of the
Fig. 2 QPCR validation of selected miRNAs confirmed the miRNA profiling results. The log2 fold-change is shown in both screening and validation
analysis for SEOC versus normal ovary with p < 0.05. The black bars represent values from screening data and bars with diagonal pattern represent
validation data
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CAOV3 and SKOV3 cells transfected with miR-31 mimic
was significantly inhibited while inhibition of miR-31 fur-
ther enhanced the SEOC cells proliferation. Similar results
were observed for the colony formation assay in which
miR-31 over-expression in SEOC cell lines markedly re-
duced the cells ability to grow and form colony (Fig. 6d),
whereby the knockdown of endogenous miR-31 increased
the cell survival to form colonies (Fig. 6e). In addition, up-
regulation of miR-31 showed a significant reduction in the
cells invasion and vice-versa when treated with miR-31 in-
hibitor (Fig. 6 f). For the migration assay, miR-31-
transfectants had their migration property reduced (Fig. 6g).
Fig. 3 MiR-200c localized in the epithelial cancer cell and inflammatory cells but absent in stroma. a The tissue was stained with H&E to identify
the cancer cellular structures. Intense LNA-miR-200c ISH signal is detected in the cytoplasmic region, predominantly in the epithelial of cancer
cells. Weak miR-200c ISH signal is seen in the stromal compartment. MiR-21 (positive control) exhibits the same pattern of localization as miR-
200c. The U6 ISH signal is solely in the nuclei of all cell types. There was no ISH signal detected in the negative control. Ca stands for cancer cells
and St stands for stroma. b Localization of miR-200c was also detected in the inflammatory cells of SEOC. All images were captured under
200× magnifications
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In contrast, the cells migration increased upon treatment
with miR-31 inhibitor (Fig. 6h).
Discussion
SEOC exhibits as the most common histological types of
ovarian cancer and patients often succumbed to the meta-
static disease. Generally, ovarian cancer patients with dif-
ferent histological subtypes received a standard, non-
personalized treatment. Therefore, search for potential
biomarkers may help in the development of a better
histological-specific treatment, hence improve patients’
outcome. Most of the cancer miRNA-based biomarkers
that have been reported thus far were from Western pop-
ulations. However, data on miRNA profile of SEOC pa-
tient in the Malaysian population has not been reported.
Here, we characterized miRNA expression profiling on a
panel of 85 cancer-related miRNAs in twenty-two un-
matched pairs of SEOC samples. The inclusion of only
serous subtype tissue within the cancer group in our study
has reduced the variations that were caused by tumor type
heterogeneity and may lead to the identification of serous-
specific biomarker.
We identified a total of 18 up-regulated and 20 down-
regulated miRNAs in SEOC versus normal ovarian sam-
ples. The miR-200 family that includes miR-141, miR-200a,
miR-200b and miR-200c were the most up-regulated miR-
NAs in our samples. These highly expressed miRNAs
showed relatively good concordance with previous studies
on SEOC [25–30]. Kan and colleagues have shown this
miRNAs family was also elevated in the serum samples of
SEOC patients [33]. We also found the same pattern of
miR-100 and miR-125b under-expression in our samples
with three other studies [26, 28, 30]. We could conclude
that the miR-200 family, miR-100 and miR-125b remain
the most consistently dysregulated in SEOC and may po-
tentially be used as the diagnostic tool for future therapy.
The high expression level of miR-200c measured by qPCR
was verified by the chromogenic LNA-ISH analysis and it
is evident that the miRNA were being expressed and local-
ized in the cytoplasm of epithelial cancer cells. We also ob-
served miR-200c ISH signal in the inflammatory cells
population which may suggest the regulation of miR-200c
on inflammation component and consequently contribute
to the invasiveness of SEOC.
Cumulative evidence has demonstrated the complex
expression and role of miR-200c in SEOC. Hence, we
used the in vitro model to understand the miR-200c ex-
pression in different stages of SEOC by using HOSE as
the normal ovarian cell, CAOV3 cell originated from
primary SEOC site and SKOV3 cell originated from asci-
tes of SEOC patient. Interestingly, we found that miR-
200c expression was significantly higher in the CAOV3
cells but dramatically down-regulated in SKOV3 cells.
Our in vitro data showed that the down-regulation of
miR-200c causes up-regulation of the tumor suppressor
gene, DLC-1. In other studies, the restoration of DLC-1
gene could effectively arrest the proliferation of ovarian
cancer cells [34] and inhibit migration and invasion in
breast cancer cells [35]. However, we observed that the
re-expression of miR-200c in the SEOC cell lines stimu-
lated cell proliferation and colonies formation but re-
presses cell migration and invasion. These observations
were consistent with previous studies investigated in
other cancer types [36, 37]. They have demonstrated that
miR-200c regulates the epithelial-mesenchymal transi-
tion by targeting ZEB1 and ZEB2, resulting in increased
expression of the cell-cell adhesion molecule, E-cadherin
and eventually causes re-epithelialization of cells to form
metastatic foci at secondary site. Our present data dem-
onstrates that miR-200c could suppress invasion and mi-
gration in SEOC cells and might add to the evidences
that miRNAs could serve as potential targets for sup-
pressing tumor metastasis.
Previously, Ren et al. has demonstrated that the ex-
pression of endogenous DLC-1 protein were low relative
to the expressions in their normal counterpart [24]. The
low expression of DLC-1 was significantly associated with
advanced FIGO stage, ascites and lymph node metastasis
[24]. Another study using the gene transfection approach
has demonstrated that the tumor suppressive activity of
DLC-1. The restoration and upregulation of DLC-1 expres-
sion could dramatically repress the proliferative potential
of ovarian cancer cells [34]. Meanwhile, the reintroduction
Fig. 4 Expression status of endogenous miR-200c and miR-31 levels
in SEOC cell lines compared to human ovarian surface epithelial
(HOSE) cells. The miR-200c level is significantly up-regulated in CAOV3
cells but extremely down-regulated in SKOV3 cells. Meanwhile, miR-31
level was significantly down-regulated both in CAOV3 and SKOV3 cells
Statistical analysis was performed using Student’s t-test. Error bars
represent standard deviation (S.D.). (***p < 0.001)
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of DLC-1 in metastatic breast cancer cell line leads to re-
duction of migration and invasion properties in both in
vitro and in vivo models [35]. This experiment confirms
that DLC-1 is not only limited to tumorigenesis but also in
metastasis. An effort linking between miRNAs function,
DLC-1 expression and metastatic properties was recently
reported by Pacurari et al. in metastatic non-small cell lung
cancer cells [13]. They have shown that the re-expression
of miR-200c in the metastatic cells could reduce DLC-1
protein level. Although we showed that miR-200c could re-
duce the DLC-1 mRNA level in SEOC cells, there is also
possibility that DLC-1 might not be a direct target of miR-
200c or be activated by other miRNAs whom their regula-
tory activities are associated with miR-200c expression.
Fig. 5 MiR-200c down-regulates DLC-1, promotes proliferation and colony formation but suppresses SEOC cells invasion and migration. a The
alignment of nucleotide sequence between the miR-200c and complementary sequence on DLC-1 3’untranslated region (UTR) interactions. The colon (:)
symbol denotes wobble base pair between guanine (G) and uracil (U) nucleotides. b QPCR showing down-regulated DLC-1 mRNA following transient
transfection of miR-200c mimic and inhibitor in SEOC cells. c The miR-200c mimic transfection promoted cell proliferation and inhibition of miR-200c
reduced cell proliferation. d Up-regulation of miR-200c enhanced colony formation but (e) down-regulation of miR-200c caused colony formation
suppression. f miR-200c over-expression increased cell invasion whereas miR-200c down-regulation reduced cell invasion. g MiR-200c inhibited cell
migration in SEOC cells and (h) The inhibition of miR-200c induced cell migration. All experiments were conducted in triplicates. Data are presented as
mean with error bars representing the S.D. Statistical analysis of the microRNA functional studies were done using t-test. (*p< 0.05,
**p < 0.01, ***p < 0.001)
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Therefore, the mechanisms on how the interaction between
miR-200c and DLC-1 in regulating SEOC clonogenic po-
tential and invasiveness need in-depth explorations.
MiR-31 expression has been reported to be frequently al-
tered in different malignancies and plays a significant role
in metastasis process. The functional role of this miRNA is
rather complicated as it can act as either tumour-
suppressive or oncogenic, depending on the cellular con-
text. MiR-31 expression was elevated in endometrial cancer
[15] but paradoxically down-regulated in breast [16] and
prostate cancer [18]. We noted that miR-31 expression was
elevated in our local samples. However, contrary to our
data, miR-31 was found down-regulated in previous studies
[29, 30]. We also observed that miR-31 was down-
regulated in the SEOC cell lines which was isolated from
Caucasian SEOC patients. Several causes may contribute to
the discrepancy of the miR-31 expression including the dif-
ferent applications of technologies in profiling miRNAs
Fig. 6 MiR-31 down-regulates AFF1, reduces SEOC cell proliferation, colony formation, invasion and migration. a The three predicted locations of miR-31
target binding sites on AFF1 3’UTR. The vertical lines denote the “seed” regions by Watson-Crick base pairing. The colon (:) symbol denotes wobble base
pair between guanine (G) and uracil (U) nucleotides. b The AFF1 expression was negatively regulated by miR-31 when measured with qPCR. c MiR-31
significantly reduced cells proliferation and inhibiting miR-31 markedly induce proliferation of SEOC cell lines. d Introduction of exogenous miR-31 into
SEOC cells significantly inhibited clonogenic potential while (e) inhibition of miR-31 exhibits the opposite effect. Representative images of crystal violet
stained colonies in each treatment were shown. f The cell invasion was assessed using pre-coated ECMatrix™ transwell membranes. g The cell migration
assay using transwell membrane showed SEOC-miR-31 transfected cells were significantly less than that of SEOC-negative controls transfected cells. (H)
Inhibition of miR-31 reversed the effects and enhanced SEOC cells migration. (*p < 0.05, **p < 0.01, ***p < 0.001, t-test)
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expression as previous studies have used the deep sequen-
cing approach. Besides, the selection of normal ovarian as
the control group may also be the contributing factor in
the disagreement as previously, primary cultured HOSE
cells were utilized as the control [29, 30]. Zorn et al. had
shown that the primary HOSE cells had a significant low
correlation of gene expression with ovarian tissue and ovar-
ian surface epithelial brushings [38]. The exposure of cells
to tissue culture conditions significantly altered gene ex-
pression by directly disturbing transcriptional regulation
[38]. Thus, our present approach comparing the results
from cancer tissues to normal ovarian tissue is more rele-
vant than the previous study that used cultured HOSE cells
as the control group.
It was reported that miR-31 expression could influence
numerous cancer-related phenotypes including cell prolif-
eration and growth, migration and metastasis. Hence, it is
of great interest to study the biological function of miR-31
in SEOC. We used exogenous miR-31 mimic to transi-
ently over-express miR-31 in vitro and observed that the
cell proliferation and colony forming ability of CAOV3
and SKOV3 were inhibited as compared to cells trans-
fected with negative control. The suppression of cell pro-
liferation and colony formation in both of the cells
indicates the significance role of miR-31 in SEOC survival.
Our in vitro miRNA functional analyses also revealed the
role of miR-31 in suppressing the key steps of tumor me-
tastasis, in which the migration and invasion of SEOC
cells were suppressed by miR-31 compared with the nega-
tive control. In breast cancer, the re-expression of miR-31
caused the reduction of metastasis [38], which shows that
miR-31 most likely play similar roles in SEOC just as
breast cancer. Similar to another study in glioblastoma,
miR-31 was shown to suppress the migration and invasion
of glioma cells by directly targeting the cytoskeletal pro-
tein, radixin [17]. Hence, it further proves that miR-31
plays an important role in regulating the cascade of inva-
sion and metastasis. We further showed that miR-31
negatively regulated the AFF1 mRNA level. The AFF1
(which is also known as AF4) is one of the super elong-
ation complex and was reported to be involved in the
transcriptional elongation misregulation that resulted in
leukemic pathogenesis [39]. In acute lymphoblastic leu-
kaemia, the down-regulation of AFF1 by miR-143 has in-
duced apoptosis and suppressed leukemic cells growth.
However, the role of AFF1 solid tumor specifically in
SEOC is not clear thus extensive work to elucidate the
mechanisms of miR-31 and AFF1 binding interaction in
this cancer shall follow.
One of the caveats of this study is the absence of the me-
tastases samples for our miRNA expression profiling. We
believe that the inclusion of metastatic tissue samples as
well as the ascites fluid could give us better insights on the
roles of miRNAs in SEOC progression. Moreover, the
qPCR panel used in this study consisted of frequently
altered miRNAs in human cancer and therefore novel miR-
NAs that may be important to SEOC were not identified.
The use of tissue array covering numerous tissue samples
of different SEOC stages and metastases counterparts as
well as normal ovarian for comparison are warranted to
provide in-depth information on miR-200c and miR-31
expressions and localizations. Future studies examining
miR-200c and miR-31 interaction with their putative tar-
gets should be tested using luciferase reporter assay and
functional studies using in vivo models may provide a bet-
ter understanding of SEOC pathogenesis.
Conclusions
Our study revealed that 38 out of 85 tested miRNAs were
aberrantly expressed in SEOC patients through qPCR ex-
pression profiling approach. We have demonstrated that
miR-200c and miR-31 significantly affects cell prolifera-
tion, clonogenic potential, migration and invasion in
SEOC cells. Our data provided insight into the identifica-
tion of miRNA-based biomarker and suggested that
modulation of these miRNAs with mimics or inhibitors
could serve as a promising cancer gene therapy for metas-
tasis inhibition in SEOC. The miRNA expression profile
together with the generated putative miRNA targets and
pathways offer a basis for future studies to understand the
metastasis mechanisms of SEOC.
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Expression of miR-31 in tissue and cell lines of serous ovarian cancer.
(A) Expression of miR-31 in serous ovarian cancer compared to the
normal ovarian tissue samples. (B) Expression of miR-31 in two serous
ovarian cancer cell lines, CAOV3 and SKOV3 compared to the HOSE, the
human normal ovarian surface epithelial cells. Data are presented as means
± standard deviation generated from triplicates. (***p < 0.05). Figure S3.
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